Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 71.16% is 15% above its 5-year average of 61.77%, near the high end of its 5-year range (58.56%–74.48%).
1.02% above its 12-month average of 70.44%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 70.71%.
GROSS MARGIN
71.16%
GROSS MARGIN AVG TTM
70.44%
GROSS MARGIN AVG 3Y
65.25%
GROSS MARGIN AVG 5Y
61.77%
GROSS MARGIN AVG 10Y
63.55%
GROSS MARGIN AVG 15Y
65.16%
GROSS MARGIN AVG 20Y
66.18%
CURRENT VS TTM AVG
+1.02%
CURRENT VS 3Y AVG
+9.05%
CURRENT VS 5Y AVG
+15.20%
CURRENT VS 10Y AVG
+11.98%
CURRENT VS 15Y AVG
+9.21%
CURRENT VS 20Y AVG
+7.53%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+20.62%
vs the sector median at left
Boston Scientific Corporation
Market Cap
$64.64B
Gross Margin
71.16%
TTM Avg
70.44%
3Y Avg
65.25%
5Y Avg
61.77%
Market Cap
$50.70B
Gross Margin
77.98%
TTM Avg
78.79%
3Y Avg
78.80%
5Y Avg
77.78%
Market Cap
$49.62B
Gross Margin
46.12%
TTM Avg
45.33%
3Y Avg
44.44%
5Y Avg
44.19%
Market Cap
$80.40B
Gross Margin
84.86%
TTM Avg
85.74%
3Y Avg
85.09%
5Y Avg
84.57%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | $64.64B | 71.16% | 70.44% | 65.25% | 61.77% |
| Moderna, Inc. (MRNA)vs › | $61.87B | 55.35% | 54.80% | 53.09% | 65.45% |
| Cencora, Inc. (COR)vs › | $59.42B | 3.71% | 3.06% | 3.07% | 2.95% |
| Cigna Corporation (CI)vs › | $72.74B | 11.66% | 9.98% | 11.47% | 12.36% |
| Cardinal Health, Inc. (CAH)vs › | $52.23B | 3.84% | 3.75% | 3.54% | 3.65% |
| Edwards Lifesciences Corporation (EW)vs › | $50.70B | 77.98% | 78.79% | 78.80% | 77.78% |
| Becton, Dickinson and Company (BDX)vs › | $49.62B | 46.12% | 45.33% | 44.44% | 44.19% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.40B | 84.86% | 85.74% | 85.09% | 84.57% |
| Humana Inc. (HUM)vs › | $45.97B | 13.65% | 14.54% | 16.14% | 17.03% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.37B | 52.47% | 50.27% | 48.88% | 48.29% |
Gross Margin
71.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 70.71% |
| 2026-03-31 | 69.44% |
| 2025-12-31 | 74.48% |
| 2025-09-30 | 69.93% |
| 2025-06-30 | 67.65% |
| 2025-03-31 | 63.26% |
| 2024-12-31 | 58.56% |
| 2024-09-30 | 62.91% |
| 2024-06-30 | 62.74% |
| 2024-03-31 | 61.83% |
| 2023-12-31 | 62.07% |
| 2023-09-30 | 61.44% |
| 2023-06-30 | 63.24% |
| 2023-03-31 | 61.29% |
| 2022-12-31 | 60.30% |
| 2022-09-30 | 60.82% |
| 2022-06-30 | 61.28% |
| 2022-03-31 | 60.91% |
| 2021-12-31 | 62.07% |
| 2021-09-30 | 62.48% |
| 2021-06-30 | 63.11% |
| 2021-03-31 | 60.57% |
| 2020-12-31 | 55.43% |
| 2020-09-30 | 59.16% |
| 2020-06-30 | 49.28% |
| 2020-03-31 | 59.50% |
| 2019-12-31 | 62.89% |
| 2019-09-30 | 63.91% |
| 2019-06-30 | 64.46% |
| 2019-03-31 | 63.94% |
| 2018-12-31 | 65.44% |
| 2018-09-30 | 66.23% |
| 2018-06-30 | 65.46% |
| 2018-03-31 | 66.75% |
| 2017-12-31 | 66.78% |
| 2017-09-30 | 64.94% |
| 2017-06-30 | 65.04% |
| 2017-03-31 | 62.82% |
| 2016-12-31 | 65.31% |
| 2016-09-30 | 64.70% |
| 2016-06-30 | 69.00% |
| 2016-03-31 | 69.86% |
| 2015-12-31 | 70.17% |
| 2015-09-30 | 70.55% |
| 2015-06-30 | 69.72% |
| 2015-03-31 | 69.63% |
| 2014-12-31 | 69.05% |
| 2014-09-30 | 69.07% |
| 2014-06-30 | 68.61% |
| 2014-03-31 | 67.47% |
| 2013-12-31 | 68.50% |
| 2013-09-30 | 68.99% |
| 2013-06-30 | 68.10% |
| 2013-03-31 | 64.85% |
| 2012-12-31 | 66.45% |
| 2012-09-30 | 67.84% |
| 2012-06-30 | 68.38% |
| 2012-03-31 | 66.18% |
| 2011-12-31 | 64.29% |
| 2011-09-30 | 63.71% |
| 2011-06-30 | 65.16% |
| 2011-03-31 | 67.22% |
| 2010-12-31 | 67.03% |
| 2010-09-30 | 67.48% |
| 2010-06-30 | 66.08% |
| 2010-03-31 | 66.17% |
| 2009-12-31 | 65.90% |
| 2009-09-30 | 68.94% |
| 2009-06-30 | 69.62% |
| 2009-03-31 | 69.80% |
| 2008-12-31 | 68.53% |
| 2008-09-30 | 66.89% |
| 2008-06-30 | 70.16% |
| 2008-03-31 | 71.65% |
| 2007-12-31 | 70.46% |
| 2007-09-30 | 71.92% |
| 2007-06-30 | 72.82% |
| 2007-03-31 | 72.77% |
| 2006-12-31 | 74.53% |
| 2006-09-30 | 68.90% |
| 2006-06-30 | 67.91% |
| 2006-03-31 | 76.91% |
| 2005-12-31 | 77.79% |
| 2005-09-30 | 77.30% |
| 2005-06-30 | 77.92% |
| 2005-03-31 | 78.70% |
| 2004-12-31 | 79.50% |
| 2004-09-30 | 79.15% |
| 2004-06-30 | 75.14% |
| 2004-03-31 | 73.01% |
| 2003-12-31 | 72.63% |
| 2003-09-30 | 72.26% |
| 2003-06-30 | 72.48% |
| 2003-03-31 | 72.00% |
| 2002-12-31 | 72.11% |
| 2002-09-30 | 70.78% |
